Morris Charles Q bought PRLD
May 1, 2026 · Form 4 insider transaction
Morris Charles Q bought 450,000 shares of Prelude Therapeutics Incorporated at $4.70 per share, a transaction worth $2.12M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
450,000
Price
$4.70
Total value
$2.12M
InsiderMorris Charles Q
RoleOfficer
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 1, 2026
Filing dateMay 4, 2026
Shares owned after450,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests as to 25% of the total shares on May 1, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.